For each portfolio company, Coronis provides seed capital, helps assemble a core team, assumes executive roles as required and oversees initial product prototyping as well as the design and completion of product development to demonstrate proof of concept. When these milestones have been achieved, Coronis orchestrates a larger follow-on financing, allowing the company to rapidly proceed to product commercialization. At this point, Coronis usually serves in an advisory capacity and provides ongoing guidance as a board member in the company.

For the entrepreneur or inventor with a novel product concept, partnership with Coronis is an excellent means of pursuing a successful commercial development effort. Coronis brings a strong funding capability to the project through its ability to provide seed capital and to leverage strong relationships with venture capital firms and other sources of financing. Due to the unique Coronis business model where operational expenses are subsidized to minimize charge back to portfolio companies, the start-up can operate economically while efficiently building value. Coronis has assembled a strong multidisciplinary team with an exceptional track record and excellent contacts in the industry. Coronis team members have managed product development from the concept stage to regulatory approval and successful commercial release. We have built numerous companies and taken them through the full lifecycle, including seed, venture, and corporate financings, IPO and acquisition. Finally, the Coronis team  is committed to assisting entrepreneurs in building companies that can save and improve lives.

Portfolio Companies:

VasoNova makes intelligent devices to guide catheters throughout the body. The company’s first product is an intelligent PICC catheter. The technology aids the clinician steering the catheter to the best anatomical position based on a specific physiologic algorithm. This ensures placing the catheter correctly upon the first attempt. The product will reduce negative outcomes, improve nursing work flow, decrease the number of confirmatory chest Xrays required and increase patient satisfaction because of fewer needle sticks. Economically, hospitals will benefit by providing drug therapy in a timely fashion increasing the likelihood of early discharge. VasoNova has identified at least 5 more applications that it intends to pursue utilizing its unique navigation technology.